Level Four Advisory Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,428
Closed -$464K – 809
2023
Q2
$464K Sell
1,428
-1,068
-43% -$305K 0.03% 494
2023
Q1
$584K Buy
2,496
+143
+6% +$36.1K 0.04% 382
2022
Q4
$593K Sell
2,353
-7
-0.3% -$1.49K 0.04% 358
2022
Q3
$419K Buy
2,360
+318
+16% +$63.9K 0.04% 347
2022
Q2
$373K Sell
2,042
-2,018
-50% -$402K 0.04% 398
2022
Q1
$1.04M Buy
4,060
+348
+9% +$79.5K 0.08% 233
2021
Q4
$854K Buy
+3,712
New +$906K 0.07% 284

Other funds holding INSP

Level Four Advisory Services's INSP Position: Q3 2023 in Review

Level Four Advisory Services sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 1,428 shares — an estimated $464K sold.

Level Four Advisory Services first reported a position in INSP in Q4 2021 and held it in 7 quarters. The position peaked at $1.04M in Q1 2022. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Level Four Advisory Services reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Level Four Advisory Services sold 1,428 Inspire Medical Systems shares in Q3 2023, an estimated $464K.
  • Level Four Advisory Services first reported a position in Inspire Medical Systems in Q4 2021 and held it in 7 quarters.
  • Level Four Advisory Services's Inspire Medical Systems position peaked at $1.04M in Q1 2022.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.